Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Rosuvastatin (ZD 4522) is an antilipemic agent that competitively inhibits hydroxymethyl-glutaryl-coenzyme A (HMG-CoA) reductase. HMG-CoA reductase catalyzes the conversion of HMG-CoA to mevalonic acid, the rate-limiting step in cholesterol biosynthesis. Rosuvastatin belongs to a class of medications called statins and is used to reduce plasma cholesterol levels and prevent cardiovascular disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 45.00 | |
10 mg | In stock | $ 73.00 | |
25 mg | In stock | $ 126.00 | |
50 mg | In stock | $ 169.00 | |
100 mg | In stock | $ 279.00 | |
200 mg | In stock | $ 391.00 |
Description | Rosuvastatin (ZD 4522) is an antilipemic agent that competitively inhibits hydroxymethyl-glutaryl-coenzyme A (HMG-CoA) reductase. HMG-CoA reductase catalyzes the conversion of HMG-CoA to mevalonic acid, the rate-limiting step in cholesterol biosynthesis. Rosuvastatin belongs to a class of medications called statins and is used to reduce plasma cholesterol levels and prevent cardiovascular disease. |
Targets&IC50 | HMG-CoA:11 nM |
Synonyms | ZD 4522 |
Molecular Weight | 481.54 |
Formula | C22H28FN3O6S |
CAS No. | 287714-41-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 199.4 mM
DMSO: 199.4 mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Rosuvastatin 287714-41-4 Autophagy Membrane transporter/Ion channel Metabolism Potassium Channel HMG-CoA Reductase Inhibitor HMG-CoA Reductase (HMGCR) repolarization KcsA cardiac durations triglycerides cholesterol action ZD 4522 low-density Hsp70 ZD4522 gene inhibit lipoprotein APDs hERG potential related QTc ZD-4522 inhibitor